⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PTHS News
Pelthos Therapeutics Inc.
Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution
globenewswire.com
ALT
PTHS
Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3%
globenewswire.com
PTHS
Form 8-K
sec.gov
OSTX
PTHS
EDVA
BLNE
Form 8-K
sec.gov
PTHS
Form 8-K
sec.gov
PTHS
Pelthos Therapeutics Announces Second Quarter 2026 Financial Results
globenewswire.com
PTHS
Form 8-K
sec.gov
PTHS
Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026
globenewswire.com
PTHS
Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders
globenewswire.com
PTHS
Pelthos Therapeutics Added to Russell 3000E™ Growth Benchmark, Russell Microcap® and Russell Microcap® Growth Benchmark Indexes
globenewswire.com
PTHS